Switching Between Epoetins: A Practice in Support of Biosimilar Use

摘要

BackgroundThe acceptability of switching between reference drugs and their biosimilars is often disputed. It is unclear whether this concern is specific to the use of biosimilars or is relevant to the practice of switching between any biological drugs.